Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study-Reference-Cited by-同舟云学术

Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study

Published:2008-05 Issue:1-2 Volume:159 Page:250-253
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Baptista Trino,Uzcátegui Euderruh,Rangel Nairy,El Fakih Yamily,Galeazzi Tatiana,Beaulieu Serge,de Baptista Enma Araujo

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference8 articles.

1. Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled study;Baptista;Schizophrenia Research,2007

2. Weight loss in overweight patients maintained on atypical antipsychotic agents;Centorrino;International Journal of Obesity,2006

3. Interventions to reduce weight gain in schizophrenia;Faulkner;Cochrane Database of Systematic Reviews,2007

4. Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome;Glueck;Metabolism,2006

5. Antipsychotic-induced venous thromboembolism: a review of the evidence;Hagg;CNS Drugs,2002

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological interventions for antipsychotic-induced weight gain in schizophrenia: A network meta-analysis;General Hospital Psychiatry;2024-09

2. Psychotropic Drug–Related Weight Gain and Its Treatment;American Journal of Psychiatry;2024-01-01

3. Pharmacological interventions for prevention of weight gain in people with schizophrenia;Cochrane Database of Systematic Reviews;2022-10-03

4. EVALUATION OF WEIGHT REDUCTION EFFICACY AND SAFETY OF SIBUTRAMIN-CONTAINING DRUGS IN PATIENTS WITH ALIMENTARY OBESITY;Pharmacy & Pharmacology;2022-07-25

5. Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis;Frontiers in Psychiatry;2021-03-17